Amit Kumar bought $53k of ANIX
Chief Executive Officer at Anixa Biosciences Inc. 21,000 shares at an average of $2.50, traded Jun 12, 2026, filed Jun 16, 2026.
Score components
- +25RoleCEO
- +7Trade size$52k at market
- 0Relative to holdingsHoldings up 3.4%
- +18Price context5% above the 52-week low; 53% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-028827, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | POpen-market purchase Common Stock | +21,000 | $2.50 | $53k | 630,812 | Jun 16, 2026 |
Related signals
Other insiders at Anixa Biosciences Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Anixa Biosciences Inc | Michael Catelani President, COO, & CFO | $16k 5,500 shares | +12% | |
| 30Weak | Anixa Biosciences Inc | Arnold M Baskies director | $14k 5,000 shares | +4% | |
| 45Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $19k 7,000 shares | +1% | |
| 46Moderate | Anixa Biosciences Inc | Lewis H Titterton jr director | $132k 49,036 shares | +5% | |
| 35Weak | Anixa Biosciences Inc | Lewis H Titterton jr director | $27k 10,000 shares | +1% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $8,250 3,000 shares | +0% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $14k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 47Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $11k 3,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.